Meihua International Medical Technologies Schedules Shareholder Meeting

Ticker: MHUAF · Form: 6-K · Filed: Oct 23, 2025 · CIK: 1835615

Meihua International Medical Technologies Co., Ltd. 6-K Filing Summary
FieldDetail
CompanyMeihua International Medical Technologies Co., Ltd. (MHUAF)
Form Type6-K
Filed DateOct 23, 2025
Risk Levellow
Pages1
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: shareholder-meeting, corporate-governance

Related Tickers: MEIP

TL;DR

Meihua Intl Medical Tech (MEIP) calling an emergency shareholder meeting - watch for news.

AI Summary

Meihua International Medical Technologies Co., Ltd. filed a Form 6-K on October 23, 2025, reporting an Extraordinary General Meeting of Shareholders. The filing includes a Notice of the meeting and a Proxy Card, indicating upcoming shareholder decisions.

Why It Matters

This filing signals that the company is convening its shareholders for important decisions, which could impact the company's future direction and shareholder value.

Risk Assessment

Risk Level: low — This is a routine filing to announce a shareholder meeting, not indicating immediate financial distress or significant operational changes.

Key Players & Entities

  • Meihua International Medical Technologies Co., Ltd. (company) — Filer of the 6-K report
  • October 23, 2025 (date) — Filing date of the 6-K
  • Extraordinary General Meeting of Shareholders (event) — Subject of the filing

FAQ

What is the purpose of the Extraordinary General Meeting of Shareholders?

The filing does not specify the exact agenda items for the Extraordinary General Meeting of Shareholders, but it indicates that a Notice and Proxy Card have been issued.

When was this Form 6-K filed?

This Form 6-K was filed on October 23, 2025.

What exhibits are attached to this filing?

Exhibits 99.1 and 99.2 are attached, which are a Notice of Extraordinary General Meeting of Shareholders and a Proxy Card, respectively.

What is the company's principal executive office address?

The company's principal executive offices are located at 88 Tongda Road, Touqiao Town, Guangling District, Yangzhou, 225000, People's Republic of China.

Does the company file annual reports under Form 20-F or 40-F?

The company indicates it files annual reports under Form 20-F.

Filing Stats: 420 words · 2 min read · ~1 pages · Grade level 12.5 · Accepted 2025-10-23 17:00:09

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO., LTD. Date: October 23, 2025 By: /s/ Leyi Lee Name: Leyi Lee Title: Chief Executive Officer 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.